Weekly shots vs daily shots for growth in short children
Part of Hormones & metabolism clinical trials.
This trial tests if a new weekly growth hormone shot (somatrogon) works as well as a daily one (Genotropin) for children who are short because they were born small or have no clear cause.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Girls must be 3 to 9 years old and not started puberty; boys must be 3 to 11 and not started puberty.
- Your child must be below the 2nd percentile in height for their age and gender.
- If born small, they had a birth weight or length below normal for how long you were pregnant.
- No other condition (like cancer, thyroid disease, or genetic problems) that causes short stature.
- No prior growth hormone treatment or medications that affect growth or weight.
- Bone age (hand X-ray) must be within normal range for their age.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called vosoritide to see if it can help children with unexplained short stature grow taller. It's for kids who are very short for their age but have normal growth hormone levels and no other known cause.
This trial tests a weekly growth hormone injection (lonapegsomatropin) compared to the standard daily growth hormone shot in children with short stature due to certain conditions. It aims to see if the weekly shot works as well or better and is safe.
This study tests whether a daily injection of human growth hormone (called Sinotropin AQ) can safely help children with unexplained short stature grow taller. It is for children who are shorter than expected but do not have a known medical reason for their short height.
This trial tests a weekly growth hormone injection called PEG-rhGH to see if it helps short children born small for gestational age grow taller. It may be an option if your child has never taken growth hormone before and meets the height and age requirements.
This trial is testing an experimental growth hormone treatment for children who are short for their age but otherwise healthy. Participation may help determine if the treatment can safely improve growth.
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
Hear when a new ISS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.